The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.50
Bid: 125.00
Ask: 130.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.00%)
Open: 127.50
High: 127.50
Low: 127.50
Prev. Close: 127.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of status to executive director and award

23 Dec 2011 09:01

RNS Number : 5750U
Transense Technologies PLC
23 December 2011
 



Transense Technologies PLC

("Transense" or the "Company")

 

23 December 2011

 

Change of status to executive director and award of options.

 

The Company is pleased to report that David M Ford, formerly a non-executive director, will assume an executive director position with immediate effect. David will be responsible for the Company's intellectual property, legal and contractual affairs.

 

The Company also announces that the following new share options have been awarded to Board members.

 

Options over 9,500,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") under the Transense 2011 Enterprise Management Incentive Option Scheme ("the Scheme") were granted yesterday to Graham Storey (CEO) and David Ford.

 

The options provide the right to subscribe for Ordinary Shares at an exercise price of £0.04 per Ordinary Share if the Company's share price reaches £0.09; the option is exercisable as set out below:

 

Director Shares Exercise Price Strike Price Exercise TermGraham Storey 6,000,000 £0.04 £0.09 Jan 2013-Jan 2018David Ford 3,500,000 £0.04 £0.09 Jan 2013-Jan 2018

 

These options have been granted in place of any previous options which have been surrendered.

 

The Remuneration Committee has resolved to grant these options on the terms set out above. In addition to the options granted to these Board members, options on similar terms were also granted to all key members of staff in place of their previous options which were also surrendered.

 

For more information, please contact:

 

Transense Technologies PLC Tel: +44 (0) 1869 238 380

Graham Storey, Chief Executive

 

Brewin Dolphin - Nomad

Neil Baldwin Tel: +44 (0) 845 213 4726

 

Hybridan LLP - Broker

Claire Noyce/Tim Goodman/Deepak Reddy Tel: +44 (0) 207 947 4350

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGCBDDBGDBGBX
Date   Source Headline
31st Jan 20227:00 amRNSNotice of Results & Investor Presentation
23rd Dec 20212:51 pmRNSHolding(s) in Company
22nd Dec 20214:11 pmRNSDirector/PDMR Shareholding
7th Dec 20214:25 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSDirector/PDMR Shareholding - Acquisition of Shares
24th Nov 20217:00 amRNSDirector/PDMR shareholding – acquisition of shares
23rd Nov 202112:47 pmRNSResult of AGM
23rd Nov 20217:00 amRNSAGM Trading Update and Director Appointments
11th Nov 202111:40 amRNSHolding(s) in Company
2nd Nov 20217:01 amRNSAppointment of Additional SAWCAP Member
2nd Nov 20217:00 amRNSAGM Attendance & Investor Presentation
27th Oct 20217:00 amRNSAnnual Report, Notice of AGM & Investor Pres
4th Oct 20217:00 amRNSGrant of Options/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results & Investor Presentation
14th Sep 20217:00 amRNS5 year JCA with McLaren Applied Ltd for SAW Tech
3rd Sep 20214:38 pmRNSHolding(s) in Company
31st Aug 20215:00 pmRNSTotal Voting Rights
26th Aug 20217:00 amRNSNotice of Annual Results & Investor Presentation
18th Aug 20213:30 pmRNSExercise of warrants
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
21st Jul 20217:00 amRNSNew member of Commercial Advisory Panel
5th Jul 20217:00 amRNSYear End Trading Update
2nd Jul 20211:12 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSDirector/PDMR Shareholding
9th Apr 202110:05 amRNSHolding(s) in Company
15th Mar 20217:00 amRNSHolding(s) in Company
19th Feb 20214:12 pmRNSHolding(s) in Company
18th Feb 20211:21 pmRNSDirector/PDMR shareholding
17th Feb 202110:34 amRNSDirector/PDMR shareholding
17th Feb 20217:00 amRNSInterim Results & Investor Presentation
12th Feb 202112:48 pmRNSFurther re. Completion of Capital Reduction
1st Feb 20217:00 amRNSNotice of Results & Investor Presentation
28th Jan 20217:00 amRNSCompletion of Capital Reduction
21st Dec 20207:00 amRNSIssue of Options
17th Dec 20201:19 pmRNSResult of AGM
17th Dec 20207:00 amRNSAGM Update, new Website & Investor Presentation
9th Dec 20207:00 amRNSEstablishment of SAW Commercial Advisory Panel
23rd Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
6th Nov 20203:38 pmRNSDirector/PDMR Shareholding
22nd Oct 20208:45 amRNSHolding(s) in Company
20th Oct 202012:09 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSFinal results for the year ended 30 June 2020
19th Oct 20207:00 amRNSChange of Nomad and Broker & AIM Rule 17 update
12th Oct 20207:00 amRNSNotice of Results and Investor Presentation
10th Sep 20207:00 amRNSFinal consideration for iTrack transfer
25th Aug 202010:23 amRNSDirector/PDMR Shareholding
24th Aug 20209:27 amRNSHolding(s) in Company (Replacement)
20th Aug 20205:02 pmRNSHolding(s) in Company
8th Jul 20204:16 pmRNSDirector/PDMR Shareholding
7th Jul 20203:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.